Wingstop Inc is a fast-casual restaurant chain that specializes in flavorful chicken wings, offering a diverse array of sauces and flavors to cater to various tastes
The company operates a franchise-based business model, allowing it to expand its footprint both domestically and internationally. In addition to wings, Wingstop's menu includes a selection of sides such as fries and coleslaw, emphasizing a casual dining experience with a focus on great taste and quality. The brand's commitment to delivering exceptional customer service and a unique dining experience has helped it carve out a significant niche in the competitive fast-food landscape.
The past six months haven’t been great for Select Medical. It just made a new 52-week low of $15.71, and shareholders have lost 55.5% of their capital. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Shareholders of Angi would probably like to forget the past six months even happened. The stock has dropped 42% and now trades at a new 52-week low of $1.53. This may have investors wondering how to approach the situation.
Boot Barn has gotten torched over the last six months - since September 2024, its stock price has dropped 33.7% to $102.45 per share. This might have investors contemplating their next move.
Vertex Pharmaceuticals trades at $500.94 and has moved in lockstep with the market. Its shares have returned 5.5% over the last six months while the S&P 500 has gained 1.6%.
Trinity currently trades at $29.55 per share and has shown little upside over the past six months, posting a small loss of 3.5%. The stock also fell short of the S&P 500’s 3.8% gain during that period.
Abbott Laboratories’s 16.6% return over the past six months has outpaced the S&P 500 by 12.8%, and its stock price has climbed to $136.50 per share. This run-up might have investors contemplating their next move.
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the modern fast food industry, including Shake Shack (NYSESHAK) and its peers.
Over the past six months, The Cheesecake Factory has been a great trade, beating the S&P 500 by 28.4%. Its stock price has climbed to $48.75, representing a healthy 33.6% increase. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
GoDaddy has had an impressive run over the past six months as its shares have beaten the S&P 500 by 8.7%. The stock now trades at $173.99, marking a 13.8% gain. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Shareholders of Biogen would probably like to forget the past six months even happened. The stock dropped 31.4% and now trades at $140.49. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
Shareholders of Caleres would probably like to forget the past six months even happened. The stock dropped 59.8% and now trades at $16.98. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
Calavo currently trades at $22.51 per share and has shown little upside over the past six months, posting a small loss of 3.8%. The stock also fell short of the S&P 500’s 5.1% gain during that period.
Over the past six months, Hologic’s stock price fell to $65.75. Shareholders have lost 17.6% of their capital, which is disappointing considering the S&P 500 has climbed by 6.4%. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
UNH is trimming its losses, 95% of the reason I didn’t take instant triple-digit profits is because the Wing Sting is so severe. United Healthcare is FAR from being done getting smashed in the face.
Over the last six months, Burlington’s shares have sunk to $243.51, producing a disappointing 10.4% loss - a stark contrast to the S&P 500’s 8.9% gain. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
